Antibody binding nanofibrils
OwnerTorleif Härd, Mats Sandgren +1inventors
InventorsTorleif Härd, Mats Sandgren, Benjamin Schmuck
Life of this patent
Estimating the term…
Abstract
The present embodiments relate to antibody binding nanofibrils obtainable by co-fibrillation of carrier proteins and carrier-Z fusion proteins at a molar ratio selected within an interval of from 1:0.20 to :0.90. The antibody binding nanofibrils have extremely high antibody binding capacity and can thereby be used in various applications, such as antibody purification, and detection of biomarkers in point of care or laboratory diagnosis applications.
Claims30
-20. (canceled)
An antibody binding nanofibril obtainable by co-fibrillation of carrier proteins and carrier-Z fusion proteins at a molar ratio selected within an interval of from 1:0.20 to 1:0.90.
A method of producing an antibody binding nanofibril, said method comprising co-fibrillating carrier proteins and carrier-Z fusion proteins at a molar ratio selected within an interval of from 1:0.20 to 1:0.90 to form said antibody binding nanofibril.
Dependencies are inferred from the claim text.